Portfolio (Quarterly)
Guide ↗
Boxer Capital Management, LLC
· CIK 0002018299| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTCT | PTC THERAPEUTICS INC | Healthcare | 200,000.0 | $12.3M | 3.91% | NEW | — | $61.37 | +28.7% |
| 2 | CYTK | CYTOKINETICS INC | Healthcare | 200,000.0 | $11.0M | 3.50% | NEW | — | $54.96 | +43.3% |
| 3 | ABVX | ABIVAX SA | Healthcare | 120,000.0 | $10.2M | 3.25% | NEW | — | $84.90 | +16.8% |
| 4 | — | INOVIO PHARMACEUTICALS INC | — | 2,300,000.0 | $5.4M | 1.72% | NEW | — | $2.34 | — |
| 5 | CELC | CELCUITY INC | Healthcare | 90,000.0 | $4.4M | 1.42% | NEW | — | $49.40 | +77.7% |
| 6 | — | SOLID BIOSCIENCES INC | — | 600,000.0 | $3.7M | 1.18% | NEW | — | $6.17 | — |
| 7 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 250,000.0 | $3.6M | 1.16% | NEW | — | $14.52 | +60.5% |
| 8 | PGEN | PRECIGEN INC | Healthcare | 850,000.0 | $2.8M | 0.89% | NEW | — | $3.29 | +46.5% |
| 9 | — | APOGEE THERAPEUTICS INC | — | 50,000.0 | $2.0M | 0.63% | NEW | — | $39.73 | — |
| 10 | — | MIND MEDICINE MINDMED INC | — | 163,500.0 | $1.9M | 0.61% | NEW | — | $11.79 | — |
| 11 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 250,000.0 | $1.8M | 0.57% | NEW | — | $7.17 | +167.9% |
| 12 | — | AVALO THERAPEUTICS INC | — | 125,000.0 | $1.6M | 0.51% | NEW | — | $12.71 | — |
| 13 | MIST | MILESTONE PHARMACEUTICALS IN | Healthcare | 666,666.0 | $1.3M | 0.42% | NEW | — | $2.00 | -35.0% |
| 14 | PEPG | PEPGEN INC | Healthcare | 250,000.0 | $1.2M | 0.37% | NEW | — | $4.62 | -61.3% |
| 15 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 70,000.0 | $1.1M | 0.35% | NEW | — | $15.79 | +90.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%